Healthcare's financial Quarter afternoon of you results. and to to Full thanks review joining for And XXXX all us Matt. Year this Fourth Definitive Thanks,
energized to plays Definitive excited ecosystem, unique by to data thousands a the providing healthcare commercialize basis. and capitalize Definitive healthcare once effectively am saying Healthcare's upon the and Healthcare in to again help Definitive that significant as Let and complex me on with role market. differentiated companies the large the I an begin in interim CEO back help of analytics be opportunity. them more I'm
I position our review call, stage growth. will for we XXXX our the as Definitive today's On an quarter overview next overall, Healthcare fourth and performance future of our results, provide discuss for of
the total was year-over-year growth, adjusted million, For margin. representing million, $XX.X fourth was our a quarter, revenue $XX.X X% and EBITDA XX%
was For $XXX.X was year-over-year revenue million, and XX% the growth, year, full adjusted million, representing total a XX% $XX.X EBITDA margin.
our with pleased are performance We quarter. the during
we year growth to and EBITDA margin macro in that at We the beginning the delivered of adjusted difficult continued guided environment XX% we the a to full show upon year.
Our in business, benefits made a customer we we and to with investments meaningful into to see a messaging clients use This important markets, to invest XXXX, across exhibited increase products remained problems. our of Definitive view of to the sales in uncertainty strong that They serve. late to products. most targeted key we for to those XXXX, But in, we Positively, experience we up most to our quarter, to leading Healthcare our cycles the critical important in XXXX. the of during retention quarter delivery their analyze to fourth of deliver what commercialization showed some in top with data right continue expect our the product the demand longer how makers. decision and prospects markets continue and trends in as continue who are the as trend began results, the which consistent funnel markets the solving
XX quarter must-haves adding success during enterprise our that our clients essential Additionally, demonstrates in these for data are and new customers. the products
allocating will for expansion, for total a from resources have we discuss most a ARR, opportunity and higher forward. at ago. segment XX% to going of are and the I year this up renew which clients, attention more enterprise our account even XX% later our now how Importantly, rate
including pressure sciences, year. to marketing limited entire during their end treat our of customer life key market wins medical life biopharma almost opinion sciences which challenging treatment affairs the and had remained patients our with half adjust under support across teams remained number therapies customer combination ARR network options an the a liver changing new of and company as lower impacted platform churn elevated perspective, continue market focused The exciting launch up Jersey-based the of in dynamics. to and that industry financing expansions these impact therapy Despite this, of for help quarter, the their the patients end with a market environment oncology during on organizations selected makes grow a leader the in to New cancer. From of a Monocl to we of
create U.S. the medtech, the and plans This company marketing we utilize identifying individual robotics within and opportunities a for in plan center, Swiss physician a on products targeting on valuable surgery. Additionally, to is platform hospital which focused market, to minimally the signed their company, surgery across entering our game and invasive sales most by organization for our market.
markets created existing ability which believe resulted dynamic this Within market, reduction across similar on as as shortages. a of which I business. needs ARR, acquisition of in the Populi new immediate an accounts of to COVID for in our than impact more churn. to talk and we XX% large saw to has has solution customer have deal about and both this XXXX, this to improved a complex our staffing expand from later. on the entire greater Based our other as will the meet well Populi our recover we had provider will significant now started by this more plan market success, we with customers The impact challenges velocity conditions end market, in our and
help them this physician markets, analyzing procedure and win referral build to in segment platform largest Massachusetts, utilization. their the by our and integrated volumes service key X physician new systems of patterns in network A in their included Populi line not-for-profit selected that diagnoses healthcare
our and great of leverage variety for services selected quarter to Healthcare customers comprised complex them out win about their XX% This multi-trillion Finally, during Definitive example sell industries a healthcare the must-have market Healthcare market that map which leader clients' of Definitive that dollar customers, diversified is into a a in market. opportunities. commercial as performed this our ARR, across An estate a well effectively global XXXX. was account of to goods in real order in help their of
our their we our integrated reinforces integrating into workflow. they're that Snowflake Additionally, instance, last our goal clients' year is launched that becoming integration heavily into partnership data an which of
with We to adjusted ability increase margins EBITDA the quarter. also our pleased were during
us XXX During deliver efforts XXXX EBITDA took efficiency. expected on adjusted to manage of drive goal full year XXXX. help proactive EBITDA beginning XX%, expenses our margin the into and these will of an increase increase actions of and benefits adjusted we in allowed and basis These margin XXXX, the point to actions in
efforts Importantly, also however, throughout attractive our invest the are reduction to us the our most in intended room to growth year give business. for cost opportunities
made us all we and organizational announcement As profitability changes, for we part set up of the made in growth. several long-term believe of which January, restructuring we
and allow amongst our overlays direct important These streamlined by by enterprise we to team. reducing will to creating increase First, sales clients. us go-to-market accountability more productivity our allocating changes team our resources go-to-market most more
relationships, these of clients enterprise fully the from offering to in allocation Additionally, will ensure to our build research more us allow shift organizations to and benefit direct our product development our provide efforts. feedback deeper entirety
more on believe impact have our business. science. Second, resources an areas the dedicated most resources includes intelligence we to immediate platform our artificial we reallocated and organization and can within investment to in our analytics product This data claims
we data in science region, our leverage tremendous and to in biopharma, investment Finally, office have Bengaluru engineering. in increased and particularly talent expertise that our
innovate. result we We impact speed savings only investment over will time, expect in able but this will are which not the at cost also to
believe that decision create to to cost to us we the restructure made, areas. the we is investment sustainable highest changes opportunity allocate free have structure the dollars long-term up difficult, always and more a While
by they us be we deep growth to is year the been digging can the As to last the will commercialization which have how XX achieve into for further our we XXXX turn for that on and future, customers focused years. innovation, turning success a help
build product to foundation powerful on differentiated products subject our deep our and and matter that XXXX evolve will offerings our flywheel meet of needs solid innovation data, of customers. flexible expertise, and our work enables rapid feed changing which proprietary pace and to analytical a in complex Our of of all at the
will the asset. on X following we our First, in to areas: proprietary In data core invest are and heavily continue XXXX, focused we
breadth We expanding focus and will continue as data well on depth quality as improving the of our data. to
data new as examples independent centers. management and well in and include as cancer and as investment Some such provider service analytics affiliations, specific infusion associations, organizations on nonstandard
on claims get use as see with our on this expansion our acquiring to to will This all we of in we analytics able look are to second here expand have and believe and visualization workflow half our more this our solutions solution in Populi to Since and this platform of provider and metrics. customers. tremendous enhanced early we attrition July technology we of into been strengthen reduce markets. and new physician opportunity seen XXXX, Second, lower a With launch in rapid business. networks. expansion the valuable expanding our platform, in will sciences impact platform this measurable their by serve they leakage have build We end their success markets, have leveraging our diversified the of life churn clients' deliver that XXXX,
science we'll Third, data insights to for in AI more clients. to and drive continue invest our
we been since founded, our continuation which here, efficient are by automating X First, data we become on areas: we science work that key Our our using science in work. concentrated to have more across the AI is were of organization is a data deep and focused
data and to AI. using new insights Second, we continue derive
understand impact proxy be that event layer entire and presentations data new new unique geographic the proprietary on influence as create found ability ecosystem include examples of a score AI of Our activity intelligence gives scientific the a new providers on scientific cannot patients to where come such A their to this us that few the from elsewhere. publications. help and to measures healthcare
we are front Thirdly, more our quickly. we ways into to can overlay intelligence in this with and data our customers explore which users our leverage technology collaborating end our help to
from to completed platform purchasing facilities another we and product technology benefit identify and acquisition, device. marketing software is most teams after in Finally, the utilized medical by line the Carevoyance sales year-end, that Carevoyance their can HX. just physicians from a or medtech
this being revenue that This meaningful more drive are can interactions standpoint, with segment in it excited provides leverage quickly executives. hospital solution of medtech illustrates our Early acquisition into is end Dataset already and purpose-built for physicians has workflow is with the a we been of that our our value to overall response is valuable integrated from with positive platform. software that our being assets clients While markets. needs our data the the and sold Atlas by small a commercial team our product and client is combining best-in-class
remain Additionally, retention. focused in customer XXXX, will keenly we on
putting initiatives such our the Populi the analytics and churn. believe product core we we discussed, As claims enhancing are asset of our data platform in reduced will expanding place use as in result
will to the we year a our as last and impact our came also However, to improving started service we began continue that churn delivery year work metrics positively close. efforts of the
We is is compete more complex with dynamic that The Healthcare than and a Definitive market future bright. TAM $XX and billion a of growing. in
with unique and healthcare. we how powerful problems, and be leveraged of in proprietary extraordinarily data that can combination analytics a products talented innovates along workforce that an client and data solve assets redefines constantly and have have mission-critical We
through me the let walk turn over to numbers. call the that, Rick With Rick? to